We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
VABYSMO (Roche Products Pty Ltd)
Product name
VABYSMO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
188 (255 working days)
Active ingredients
faricimab
Registration type
EOI
Indication
Macular oedema secondary to retinal vein occlusion (RVO).